J&J, drug distributors sign off on a mammoth $26B opioid settlement with 46 states
Three major drug distributors and Johnson & Johnson have the numbers they need to move forward with a mammoth settlement that will lay to rest a majority of the state and local opioid lawsuits filed against them.
Of 49 eligible states, 46 — plus DC — have agreed to join the settlement, AmerisourceBergen, Cardinal Health and McKesson announced on Friday. More than 90% of eligible political subdivisions agreed to participate or had their claims addressed by state legislation.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.